Akston Biosciences Corporation.
Latest round
- Series E
Last raised
- Apr 2019
Total raised
- Undisclosed
Investors
- 2
About Akston Biosciences Corporation.
Based in Massachusetts, US, and founded in 2011 by Todd Zion (CEO), and others, Akston Biosciences Corporation, is a biotechnology company that leverages its novel fusion protein platform to develop and manufacture new classes of biologics. In March 2022, Akston Biosciences Corporation. Akston, along with the Strides Group's Biolexis Private Limited manufactures and commercializes covid vaccines AKS-452 in India and over 130 countries in Asia, Latin America, and Africa. The firm has also collaborated with Dechra Pharmaceuticals PLC (DPH) to commercialize insulin therapies for canines and felines. The firm employs its proprietary Fc-fusion platform to develop therapeutic antibodies that specifically tailor the different components of a moiety to optimize its performance and manufacturability to help treat a wide variety of diseases. The therapeutic companies thus created can be produced on a large scale using techniques and tools that are industry standard for producing biologics including vaccines, ultra-long-acting insulins, and autoimmune disease therapies.
Who invested in Akston Biosciences Corporation.
2 investors across 1 round
See all investors in Akston Biosciences Corporation.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Apr 4, 2019
Amount
Undisclosed
Investors
Questions about Akston Biosciences Corporation.
Who invested in Akston Biosciences Corporation.?
Akston Biosciences Corporation. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Akston Biosciences Corporation. raised?
Akston Biosciences Corporation. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Akston Biosciences Corporation. last raise money?
Akston Biosciences Corporation.'s most recent round on record is a Series E, in Apr 2019.
What does Akston Biosciences Corporation. do?
Based in Massachusetts, US, and founded in 2011 by Todd Zion (CEO), and others, Akston Biosciences Corporation, is a biotechnology company that leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Where is Akston Biosciences Corporation. headquartered?
Akston Biosciences Corporation. is headquartered in Beverly, US.
Which VCs invest in companies like Akston Biosciences Corporation.?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Akston Biosciences Corporation.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Akston Biosciences Corporation.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.